ACLARIS THERAPEUTICS INC's ticker is and the CUSIP is 00461U905. A total of 5 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,867,995 | +191.0% | 272,700 | +340.5% | 0.01% | +200.0% |
| Q2 2023 | $641,903 | +8.4% | 61,900 | -15.4% | 0.00% | 0.0% |
| Q1 2023 | $592,188 | +279.8% | 73,200 | +639.4% | 0.00% | – |
| Q4 2022 | $155,925 | -12.4% | 9,900 | -12.4% | 0.00% | – |
| Q3 2022 | $178,000 | +109.4% | 11,300 | +85.2% | 0.00% | – |
| Q2 2022 | $85,000 | -52.2% | 6,100 | -40.8% | 0.00% | – |
| Q1 2022 | $178,000 | -64.0% | 10,300 | -69.7% | 0.00% | – |
| Q4 2021 | $494,000 | +997.8% | 34,000 | +1260.0% | 0.00% | – |
| Q3 2021 | $45,000 | -82.1% | 2,500 | -82.5% | 0.00% | – |
| Q2 2021 | $251,000 | -69.2% | 14,300 | -55.9% | 0.00% | -100.0% |
| Q1 2021 | $816,000 | +482.9% | 32,400 | +50.0% | 0.00% | – |
| Q4 2020 | $140,000 | +13900.0% | 21,600 | +5300.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 400 | -42.9% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 700 | -70.8% | 0.00% | – |
| Q4 2019 | $5,000 | +400.0% | 2,400 | +140.0% | 0.00% | – |
| Q3 2019 | $1,000 | -99.2% | 1,000 | -94.0% | 0.00% | -100.0% |
| Q4 2018 | $123,000 | -9.6% | 16,600 | +232.0% | 0.00% | 0.0% |
| Q2 2017 | $136,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 272,700 | $1,867,995 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 70,800 | $484,980 | 0.00% |
| SIMPLEX TRADING, LLC | 54,700 | $374 | 0.00% |
| JANE STREET GROUP, LLC | 127,700 | $874,745 | 0.00% |